GlassScriptPhysician profile
Sharon Resto
NPI 1861005464
$1,400.44
in general payments reported to CMS, 2019-2025
24 companies · $449 in 2025
The $449 reported for 2025 was more than what 84% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.90 · 2022: $200 · 2023: $327 · 2024: $409 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.93 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $245.31 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $185.00 | 2023-2025 | Slynd |
| Abbvie INC. | $164.57 | 2021-2024 | |
| Organon LLC | $66.54 | 2022-2024 | Nexplanon |
| Shield Therapeutics INC | $62.37 | 2023-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $62.25 | 2024-2025 | Myfembree |
| Exact Sciences Corporation | $59.84 | 2025 | The Cologuard Plus Collection Kit |
| Mayne Pharma Commercial LLC | $59.51 | 2023-2024 | |
| Pfizer INC. | $56.97 | 2023-2024 | |
| Coopersurgical, INC. | $53.19 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $47.14 | 2024-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Millicent US INC | $45.69 | 2024-2025 | Intrarosa |
| Sage Therapeutics, LLC | $41.07 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.19 | 2023 | |
| Gynesonics, INC. | $34.29 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $31.94 | 2023-2024 | Twirla |
| Myovant Sciences INC. | $24.95 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $24.61 | 2022 | |
| Daiichi Sankyo INC. | $22.15 | 2022 | |
| Evofem Biosciences, INC. | $18.39 | 2022 | |
| Currax Pharmaceuticals LLC | $15.89 | 2024 | Contrave |
| Axonics, INC. | $14.88 | 2023 | Bulkamid, Axonics |
| Therapeuticsmd, INC. | $13.64 | 2022 | |
| Avion Pharmaceuticals | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Resto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.